Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Vitamin D Therapy in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis Publisher Pubmed



Sohouli MH1, 2 ; Farahmand F1 ; Alimadadi H1 ; Rahmani P1 ; Motamed F1 ; Da Silva Magalhaes EI3 ; Rohani P1, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pediatric Gastroenterology and Hepatology Research Center, Pediatrics Centre of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Postgraduate Programme in Collective Health, Federal University of Maranhao, Rua Barao de Itapary, 155, Centro, MA, Sao Luis, Brazil
  4. 4. Pediatrics Gastroenterology, Department of Pediatrics, School of Medicine, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

Source: World Journal of Pediatrics Published:2023


Abstract

Background: There is some evidence for the role of vitamin D deficiency in the pathogenesis of inflammatory bowel disease (IBD) in the pediatric population. However, the results are contradictory. Therefore, we have conducted a systematic review and meta-analysis to evaluated the effect of vitamin D on pediatric patients with IBD. Methods: We carried out a systematic search in databases from inception until 20 January 2022. We included all relevant articles that evaluate the efficacy and safety of vitamin D on disease activity, inflammatory factors, and vitamin D and calcium levels in pediatric patients with IBD. Random effects models were used to combine the data. The main outcomes were then analyzed using weight mean difference (WMD) and respective 95% confidence interval (CI). Results: Fifteen treatment arms met the eligibility criteria and were included. Pooled estimates indicated that intervention with vitamin D has a significantly beneficial effect on 25-hydroxyvitamin D3 [25(OH) D3] (pooled WMD of 17.662 ng/mL; CI 9.77–25.46; P < 0.001), calcium (pooled WMD of 0.17 mg/dL; CI 0.04–0.30; P = 0.009), and inflammatory factors including C-reactive protein (CRP) (pooled WMD of −6.57 mg/L; CI −11.47 to −1.67; P = 0.009) and erythrocyte sedimentation rate (ESR) (pooled WMD of −7.94 mm/h; CI −12.65 to −3.22; P = 0.001) levels. In addition, this effect was greater for vitamin D levels at doses greater than 2000 IU, and when follow-up duration was more than 12 weeks. Conclusion: This study showed that vitamin D therapy can have a significant and beneficial effect on 25(OH) D3, calcium, and inflammatory factors in children and adolescents with IBD. © 2022, Children's Hospital, Zhejiang University School of Medicine.
Other Related Docs
37. Prevalence of Preeclampsia and Eclampsia in Iran, Archives of Iranian Medicine (2016)